Terms: = Uterine cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Prognosis
5 results:
1. Prognostic significance of atypical mitotic figures in smooth muscle tumors of uncertain malignant potential (STUMP) of the uterus and uterine adnexa.
Travaglino A; Raffone A; Santoro A; Gencarelli A; Angelico G; Spadola S; Marzullo L; Zullo F; Insabato L; Zannoni GF
APMIS; 2021 Apr; 129(4):165-169. PubMed ID: 33445214
[TBL] [Abstract] [Full Text] [Related]
2. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
[TBL] [Abstract] [Full Text] [Related]
3. Adjuvant Therapy Use and Survival in Stage II Endometrial cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract] [Full Text] [Related]
4. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival.
Giuntoli RL; Gerardi MA; Yemelyanova AV; Ueda SM; Fleury AC; Diaz-Montes TP; Bristow RE
Int J Gynecol Cancer; 2012 Feb; 22(2):273-9. PubMed ID: 22146771
[TBL] [Abstract] [Full Text] [Related]
5. [Changes in the clinical picture, morphology and therapy of endometrial carcinoma over 3 decades].
Bartl W; Breitenecker G; Endler M; Tatra G
Onkologie; 1984 Jun; 7(3):128-36. PubMed ID: 6379532
[TBL] [Abstract] [Full Text] [Related]
